The MPL mutation (found in about 1-2% of MPN cases) is one of the less common gene mutations associated with MPNs, particularly essential thrombocythemia (ET) and primary myelofibrosis (PMF). Life expectancy can vary quite a bit depending on several factors beyond just the specific mutation.
Here are some key factors that Show Full Answer
The MPL mutation (found in about 1-2% of MPN cases) is one of the less common gene mutations associated with MPNs, particularly essential thrombocythemia (ET) and primary myelofibrosis (PMF). Life expectancy can vary quite a bit depending on several factors beyond just the specific mutation.
Here are some key factors that influence life expectancy with MPNs:
- Type of MPN — ET generally has a closer-to-normal life expectancy, while PMF tends to have a shorter one
- Age at diagnosis — Younger people typically have better outcomes
- Risk group — Low, intermediate, or high risk classifications matter significantly
- White blood cell count — Higher counts can indicate more severe disease
- Number of gene mutations — More mutations can mean a worse prognosis
- History of blood clots — This can shorten life expectancy
General survival estimates by MPN type include:
- ET — Often near-normal lifespan
- PV — Median survival around 15 years
- PMF (low risk) — Median survival around 15.4 years
- PMF (high risk) — Median survival around 1.3 years
It's really important to speak with a hematologist or MPN specialist who can look at the full picture of your health to give a more personalized outlook. These numbers are estimates based on large groups of people — individual experiences vary widely.
November 2
Join
Your Privacy Choices
